Epidemiology  of HAP/VAP: The real burden

I. Martin-Loeches (Dublin 8, Ireland)

Source: International Congress 2017 – Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-associated pneumonia (VAP)
Disease area: Respiratory critical care, Respiratory infections

WebcastSlide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Martin-Loeches (Dublin 8, Ireland). Epidemiology  of HAP/VAP: The real burden. International Congress 2017 – Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-associated pneumonia (VAP)

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Belief about cure of disease after dots
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014

Are the Roma population risk group for tuberculosis?
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013


Differences in disease severity between combination treatments in a Swedish population
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Tuberculosis lineage in a low prevalence area; epidemiology and clinical characteristics
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013

The disease burden of mild asthma: Findings from a 2013 real world survey
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016


Epidemiology: development and perspectives
Source: Eur Respir Monogr 2015; 68: 1-11
Year: 2015


The global burden of pneumonia in China and the world: a Global Burden of Disease comparison
Source: International Congress 2019 – Chinese programme 2019: Part II
Year: 2019


Epidemiology and clinical features of nontuberculous mycobacterial lung disease in a subtropical region in Japan: Analysis with a 7-year data in two major hospitals
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016


The causes of death among patients with tuberculosis
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015

Risk factors for pulmonary tuberculosis in Croatia
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013

Epidemiology of communicable diseases: tuberculosis
Source: Online Course 2014 - Respiratory epidemiology
Year: 2014


Estimating severe asthma prevalence in austria using nationwide prescription data
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015

Productivity losses in COPD – A population-based survey.
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014

LATE-BREAKING ABSTRACT: The effectiveness of clinical Influenza diagnosis in a Belgian out-patient setting identifies the need for rapid diagnostic assays
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


A novel score of respiratory health predicts hospitalizations in children
Source: International Congress 2014 – Emerging concepts in respiratory disease
Year: 2014

Risk factors for tuberculosis relapse in Polish patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013

Epidemiology
Source: Eur Respir Monogr 2016; 71: 1-15
Year: 2016